APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu Shots

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Flu Shots Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchFlu Shots Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu Shots Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Flu Shots Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu Shots Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu Shots Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Flu Shots market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flu Shots market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flu Shots and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flu Shots sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flu Shots market size, projected growth trends, production technologies, key applications, and end-use industries.

Flu Shots Segment by Company

SANOFI

GSK

VAXTEC

TIANYUAN BIO-PHARMA

SIOBP

SINOVAC

LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT

HUALAN BIO

CHANGSHENG

CCBIO

ALEPH BIOMEDICAL

Flu Shots Segment by Type

Influenza Whole Virus Vaccines

Influenza Virus Subunit Vaccines

Influenza Virus Split Vaccines

Flu Shots Segment by Application

Avian Influenza Virus-A

Avian Influenza Virus-B

Flu Shots Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flu Shots market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Flu Shots Industry Trends Table 2. Flu Shots Industry Drivers Table 3. Flu Shots Industry Opportunities and Challenges Table 4. Flu Shots Industry Restraints Table 5. Global Flu Shots Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Flu Shots Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Flu Shots Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Flu Shots Sales Market Share by Manufacturers Table 9. Global Flu Shots Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Flu Shots Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Flu Shots Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Flu Shots Manufacturers, Product Type & Application Table 13. Global Flu Shots Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Flu Shots by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Influenza Whole Virus Vaccines Table 17. Major Manufacturers of Influenza Virus Subunit Vaccines Table 18. Major Manufacturers of Influenza Virus Split Vaccines Table 19. Global Flu Shots Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Flu Shots Sales by Type (2021-2026) & (K Units) Table 21. Global Flu Shots Sales by Type (2027-2032) & (K Units) Table 22. Global Flu Shots Sales Market Share by Type (2021-2026) Table 23. Global Flu Shots Sales Market Share by Type (2027-2032) Table 24. Global Flu Shots Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Flu Shots Revenue by Type (2021-2026) & (K Units) Table 26. Global Flu Shots Revenue by Type (2027-2032) & (K Units) Table 27. Global Flu Shots Revenue Market Share by Type (2021-2026) Table 28. Global Flu Shots Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Avian Influenza Virus-A Table 30. Major Manufacturers of Avian Influenza Virus-B Table 31. Global Flu Shots Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Flu Shots Sales by Application (2021-2026) & (K Units) Table 33. Global Flu Shots Sales by Application (2027-2032) & (K Units) Table 34. Global Flu Shots Sales Market Share by Application (2021-2026) Table 35. Global Flu Shots Sales Market Share by Application (2027-2032) Table 36. Global Flu Shots Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Flu Shots Revenue by Application (2021-2026) & (K Units) Table 38. Global Flu Shots Revenue by Application (2027-2032) & (K Units) Table 39. Global Flu Shots Revenue Market Share by Application (2021-2026) Table 40. Global Flu Shots Revenue Market Share by Application (2027-2032) Table 41. Global Flu Shots Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Flu Shots Sales by Region (2021-2026) & (K Units) Table 43. Global Flu Shots Sales Market Share by Region (2021-2026) Table 44. Global Flu Shots Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Flu Shots Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Flu Shots Sales by Country (2021-2026) & (K Units) Table 48. North America Flu Shots Sales by Country (2027-2032) & (K Units) Table 49. Europe Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Flu Shots Sales by Country (2021-2026) & (K Units) Table 51. Europe Flu Shots Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Flu Shots Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Flu Shots Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Flu Shots Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Flu Shots Sales by Country (2027-2032) & (K Units) Table 58. Global Flu Shots Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Flu Shots Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Flu Shots Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Flu Shots Revenue Market Share by Region (2021-2026) Table 62. Global Flu Shots Revenue Market Share by Region (2027-2032) Table 63. SANOFI Company Information Table 64. SANOFI Business Overview Table 65. SANOFI Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. SANOFI Flu Shots Product Portfolio Table 67. SANOFI Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GSK Flu Shots Product Portfolio Table 72. GSK Recent Development Table 73. VAXTEC Company Information Table 74. VAXTEC Business Overview Table 75. VAXTEC Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. VAXTEC Flu Shots Product Portfolio Table 77. VAXTEC Recent Development Table 78. TIANYUAN BIO-PHARMA Company Information Table 79. TIANYUAN BIO-PHARMA Business Overview Table 80. TIANYUAN BIO-PHARMA Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. TIANYUAN BIO-PHARMA Flu Shots Product Portfolio Table 82. TIANYUAN BIO-PHARMA Recent Development Table 83. SIOBP Company Information Table 84. SIOBP Business Overview Table 85. SIOBP Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. SIOBP Flu Shots Product Portfolio Table 87. SIOBP Recent Development Table 88. SINOVAC Company Information Table 89. SINOVAC Business Overview Table 90. SINOVAC Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. SINOVAC Flu Shots Product Portfolio Table 92. SINOVAC Recent Development Table 93. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information Table 94. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview Table 95. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio Table 97. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Development Table 98. HUALAN BIO Company Information Table 99. HUALAN BIO Business Overview Table 100. HUALAN BIO Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. HUALAN BIO Flu Shots Product Portfolio Table 102. HUALAN BIO Recent Development Table 103. CHANGSHENG Company Information Table 104. CHANGSHENG Business Overview Table 105. CHANGSHENG Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. CHANGSHENG Flu Shots Product Portfolio Table 107. CHANGSHENG Recent Development Table 108. CCBIO Company Information Table 109. CCBIO Business Overview Table 110. CCBIO Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. CCBIO Flu Shots Product Portfolio Table 112. CCBIO Recent Development Table 113. ALEPH BIOMEDICAL Company Information Table 114. ALEPH BIOMEDICAL Business Overview Table 115. ALEPH BIOMEDICAL Flu Shots Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. ALEPH BIOMEDICAL Flu Shots Product Portfolio Table 117. ALEPH BIOMEDICAL Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Flu Shots Distributors List Table 121. Flu Shots Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Flu Shots Product Image Figure 2. Global Flu Shots Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu Shots Market Size (2021-2032) & (US$ Million) Figure 4. Global Flu Shots Sales (2021-2032) & (K Units) Figure 5. Global Flu Shots Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Flu Shots Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Influenza Whole Virus Vaccines Image Figure 9. Influenza Virus Subunit Vaccines Image Figure 10. Influenza Virus Split Vaccines Image Figure 11. Global Flu Shots Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Flu Shots Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Flu Shots Sales Market Share by Type (2021-2032) Figure 14. Global Flu Shots Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Flu Shots Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Flu Shots Revenue Market Share by Type (2021-2032) Figure 17. Avian Influenza Virus-A Image Figure 18. Avian Influenza Virus-B Image Figure 19. Global Flu Shots Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Flu Shots Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Flu Shots Sales Market Share by Application (2021-2032) Figure 22. Global Flu Shots Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Flu Shots Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Flu Shots Revenue Market Share by Application (2021-2032) Figure 25. North America Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Flu Shots Sales Market Share by Country (2021-2032) Figure 27. U.S. Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Flu Shots Sales Market Share by Country (2021-2032) Figure 32. Germany Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Flu Shots Sales Market Share by Country (2021-2032) Figure 39. China Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Flu Shots Sales Market Share by Country (2021-2032) Figure 47. Brazil Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Flu Shots Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Flu Shots Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Flu Shots Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Flu Shots Revenue (2021-2032) & (US$ Million) Figure 58. North America Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Flu Shots Revenue (2021-2032) & (US$ Million) Figure 60. Europe Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Flu Shots Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Flu Shots Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Flu Shots Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Flu Shots Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Influenza Whole Virus Vaccines
  • Influenza Virus Subunit Vaccines
  • Influenza Virus Split Vaccines
Applications
  • Avian Influenza Virus-A
  • Avian Influenza Virus-B
Companies covered
  • SANOFI
  • GSK
  • VAXTEC
  • TIANYUAN BIO-PHARMA
  • SIOBP
  • SINOVAC
  • LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
  • HUALAN BIO
  • CHANGSHENG
  • CCBIO
  • ALEPH BIOMEDICAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Flu Shots Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Flu Shots Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Flu Shots Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Flu Shots Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Flu Shots Market Dynamics
  1. 2.1 Flu Shots Industry Trends
  2. 2.2 Flu Shots Industry Drivers
  3. 2.3 Flu Shots Industry Opportunities and Challenges
  4. 2.4 Flu Shots Industry Restraints
3 Flu Shots Market by Manufacturers
  1. 3.1 Global Flu Shots Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Flu Shots Sales by Manufacturers (2021-2026)
  3. 3.3 Global Flu Shots Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Flu Shots Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Flu Shots Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Flu Shots Manufacturers, Product Type & Application
  7. 3.7 Global Flu Shots Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Flu Shots Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Flu Shots Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Flu Shots Tier 1, Tier 2, and Tier 3
4 Flu Shots Market by Type
  1. 4.1 Flu Shots Type Introduction
  2. 4.1.1 Influenza Whole Virus Vaccines
  3. 4.1.2 Influenza Virus Subunit Vaccines
  4. 4.1.3 Influenza Virus Split Vaccines
  5. 4.2 Global Flu Shots Sales by Type
  6. 4.2.1 Global Flu Shots Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Flu Shots Sales by Type (2021-2032)
  8. 4.2.3 Global Flu Shots Sales Market Share by Type (2021-2032)
  9. 4.3 Global Flu Shots Revenue by Type
  10. 4.3.1 Global Flu Shots Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Flu Shots Revenue by Type (2021-2032)
  12. 4.3.3 Global Flu Shots Revenue Market Share by Type (2021-2032)
5 Flu Shots Market by Application
  1. 5.1 Flu Shots Application Introduction
  2. 5.1.1 Avian Influenza Virus-A
  3. 5.1.2 Avian Influenza Virus-B
  4. 5.2 Global Flu Shots Sales by Application
  5. 5.2.1 Global Flu Shots Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Flu Shots Sales by Application (2021-2032)
  7. 5.2.3 Global Flu Shots Sales Market Share by Application (2021-2032)
  8. 5.3 Global Flu Shots Revenue by Application
  9. 5.3.1 Global Flu Shots Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Flu Shots Revenue by Application (2021-2032)
  11. 5.3.3 Global Flu Shots Revenue Market Share by Application (2021-2032)
6 Global Flu Shots Sales by Region
  1. 6.1 Global Flu Shots Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flu Shots Sales by Region (2021-2032)
  3. 6.2.1 Global Flu Shots Sales by Region (2021-2026)
  4. 6.2.2 Global Flu Shots Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Flu Shots Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Flu Shots Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Flu Shots Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Flu Shots Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Flu Shots Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Flu Shots Revenue by Region
  1. 7.1 Global Flu Shots Revenue by Region
  2. 7.1.1 Global Flu Shots Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Flu Shots Revenue by Region (2021-2026)
  4. 7.1.3 Global Flu Shots Revenue by Region (2027-2032)
  5. 7.1.4 Global Flu Shots Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Flu Shots Revenue (2021-2032)
  8. 7.2.2 North America Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Flu Shots Revenue (2021-2032)
  11. 7.3.2 Europe Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Flu Shots Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Flu Shots Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Flu Shots Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 SANOFI
  2. 8.1.1 SANOFI Company Information
  3. 8.1.2 SANOFI Business Overview
  4. 8.1.3 SANOFI Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SANOFI Flu Shots Product Portfolio
  6. 8.1.5 SANOFI Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Flu Shots Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 VAXTEC
  14. 8.3.1 VAXTEC Company Information
  15. 8.3.2 VAXTEC Business Overview
  16. 8.3.3 VAXTEC Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 VAXTEC Flu Shots Product Portfolio
  18. 8.3.5 VAXTEC Recent Developments
  19. 8.4 TIANYUAN BIO-PHARMA
  20. 8.4.1 TIANYUAN BIO-PHARMA Company Information
  21. 8.4.2 TIANYUAN BIO-PHARMA Business Overview
  22. 8.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
  24. 8.4.5 TIANYUAN BIO-PHARMA Recent Developments
  25. 8.5 SIOBP
  26. 8.5.1 SIOBP Company Information
  27. 8.5.2 SIOBP Business Overview
  28. 8.5.3 SIOBP Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SIOBP Flu Shots Product Portfolio
  30. 8.5.5 SIOBP Recent Developments
  31. 8.6 SINOVAC
  32. 8.6.1 SINOVAC Company Information
  33. 8.6.2 SINOVAC Business Overview
  34. 8.6.3 SINOVAC Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SINOVAC Flu Shots Product Portfolio
  36. 8.6.5 SINOVAC Recent Developments
  37. 8.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
  38. 8.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information
  39. 8.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
  40. 8.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
  42. 8.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
  43. 8.8 HUALAN BIO
  44. 8.8.1 HUALAN BIO Company Information
  45. 8.8.2 HUALAN BIO Business Overview
  46. 8.8.3 HUALAN BIO Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HUALAN BIO Flu Shots Product Portfolio
  48. 8.8.5 HUALAN BIO Recent Developments
  49. 8.9 CHANGSHENG
  50. 8.9.1 CHANGSHENG Company Information
  51. 8.9.2 CHANGSHENG Business Overview
  52. 8.9.3 CHANGSHENG Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CHANGSHENG Flu Shots Product Portfolio
  54. 8.9.5 CHANGSHENG Recent Developments
  55. 8.10 CCBIO
  56. 8.10.1 CCBIO Company Information
  57. 8.10.2 CCBIO Business Overview
  58. 8.10.3 CCBIO Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CCBIO Flu Shots Product Portfolio
  60. 8.10.5 CCBIO Recent Developments
  61. 8.11 ALEPH BIOMEDICAL
  62. 8.11.1 ALEPH BIOMEDICAL Company Information
  63. 8.11.2 ALEPH BIOMEDICAL Business Overview
  64. 8.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
  66. 8.11.5 ALEPH BIOMEDICAL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flu Shots Value Chain Analysis
  2. 9.1.1 Flu Shots Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flu Shots Production Mode & Process
  6. 9.2 Flu Shots Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flu Shots Distributors
  9. 9.2.3 Flu Shots Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst